#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal artery occlusion Rheumatoid arthritis Non-Hodgkin's lymphoma refractory Spinal muscular atrophy Peritoneal mesothelioma malignant Frontotemporal dementia Primary adrenal insufficiency Alternating hemiplegia of childhood Primary hyperoxaluria Dedifferentiated liposarcoma Vaginal cancer Progressive multifocal leukoencephalopathy Spina bifida Hepatocellular carcinoma Paroxysmal nocturnal haemoglobinuria More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Trials in Disease Prolymphocytic leukaemia – Life with Disease Acute respiratory distress syndrome – Treatment Bronchiolitis obliterans syndrome – Diagnostics Glycogen storage disease type II – Trials in Disease Amyotrophic lateral sclerosis – Trials in Disease Synovial sarcoma metastatic – Life with Disease Carcinoid syndrome – Trials in Disease Hereditary neuropathic amyloidosis – Trials in Disease Pulmonary sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GT-002 Efmoroctocog Alfa Padeliporfin Calcium Chloride Hexahydrate Rasagiline Capecitabine Hydrocortisone Hemisuccinate Avacopan YOHIMBINE HYDROCHLORIDE Sodium Zirconium Cyclosilicate Vedolizumab Belzupacap Sarotalocan Benralizumab Imsidolimab Betula Alba Pollen Extract Crofelemer AZD3632 Mps-102 Dalbavancin Elranatamab More therapies…

    Learn about Your Condition

    Cystic fibrosis Contusion H1N1 influenza Lipid metabolism disorder Soft tissue sarcoma Benign renal neoplasm Tissue anoxia Impaired gastric emptying Pyoderma Pseudomyxoma peritonei Hypoparathyroidism Bladder cancer recurrent Breast cancer stage I Post procedural complication Congenital myopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Deafness

  • Study on the Effects of Intracochlear Triamcinolone Acetonide for Patients with Persistent Sudden Sensorineural Hearing Loss After Unsuccessful Conservative Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Deafness
    • Deafness neurosensory
    Investigated Drugs:
    • Triamcinolone Acetonide
    Austria

  • Study on Long-Term Safety of AAVAnc80-hOTOF Gene Therapy for Patients with Sensorineural Hearing Loss Due to Otoferlin Gene Mutations

    Recruiting

    4 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Aavanc80-3’Hotof
    • Aavanc80-5’Hotof
    Spain

  • Study on DB-OTO for Safety and Tolerability in Infants and Children with Genetic Hearing Loss

    Recruiting

    2 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Db-Oto-3
    • Db-Oto-5
    Germany Spain

  • Study on Meniere’s Disease: Comparing Methylprednisolone and Placebo for Patients with Unilateral Meniere’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deafness
    • Dizziness
    • Ear discomfort
    Investigated Drugs:
    • Gentamicin
    • Metoclopramide
    • Triamcinolone Acetonide
    The Netherlands

  • Study of Aspirin and Folic Acid Treatment for Patients with Sudden Sensorineural Hearing Loss

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Folic Acid
    • Acetylsalicylic Acid
    France

  • Study on Gene Therapy AAVAnc80-hOTOF for Patients with Sensorineural Hearing Loss from Otoferlin Gene Mutations

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Aavanc80-3’Hotof
    • Aavanc80-5’Hotof
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!